Extracellular vesicles in cardiovascular disease therapy

  • 289

    Total views and downloads

About this Research Topic

Submission deadlines

  1. Manuscript Submission Deadline 22 March 2027

  2. This Research Topic is currently accepting articles

Background

Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide, imposing a substantial global health and economic burden. Despite significant advances in pharmacological and interventional therapies, critical gaps persist in early detection, tissue repair, and long-term disease management: particularly in conditions such as heart failure, myocardial infarction, cardiac fibrosis, atherosclerosis, and arrhythmogenic cardiomyopathies.

Extracellular vesicles (EVs), including exosomes and microvesicles, have emerged as key mediators of intercellular communication in the cardiovascular system. By trafficking bioactive cargo, including coding and non-coding RNAs (such as microRNAs, long non-coding RNAs), proteins, and lipids, EVs regulate fundamental processes such as cardiac remodeling, vascular inflammation, smooth muscle cell function, and myocardial tissue repair. These properties position EVs at the intersection of cardiovascular pathophysiology and pharmacology, opening new avenues for therapeutic delivery, target identification, and disease monitoring.

This Research Topic brings together cutting-edge original research and comprehensive reviews at the frontier of EV biology and cardiovascular pharmacology. We welcome contributions covering:

• Molecular mechanisms governing EV biogenesis, cargo loading, and uptake in cardiac and smooth muscle cell contexts
• Coding (mRNA) and Non-coding RNA cargo (miRNAs, lncRNAs, tRNA fragments) as pharmacological targets or therapeutic tools in CVD
• EV engineering strategies for targeted cardiac drug delivery and vascular intervention
• EV-based liquid biopsy approaches for cardiovascular biomarker discovery and disease monitoring
• Pharmacological modulation of EV release, uptake, and function
• Epigenetic regulation of EV-mediated cardiovascular signaling
• Translational models and clinical development pipelines for EV-based cardiovascular therapeutics
• By integrating molecular insights with pharmacological innovation, this Research Topic aims to accelerate the translation of EV biology from bench discovery to clinical application in cardiovascular medicine.

Article types and fees

This Research Topic accepts the following article types, unless otherwise specified in the Research Topic description:

  • Brief Research Report
  • Case Report
  • Editorial
  • FAIR² Data
  • General Commentary
  • Hypothesis and Theory
  • Methods
  • Mini Review
  • Opinion

Articles that are accepted for publication by our external editors following rigorous peer review incur a publishing fee charged to Authors, institutions, or funders.

Keywords: Extracellular vesicles, Cardiovascular diseases, Bioactive cargo, Exosomes, Microvesicles, Myocardial infarction, Cardiac remodeling, Cardiovascular pharmacology, EV-based liquid biopsy, Biomarker discovery

Important note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Topic editors

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

  • 289Topic views
View impact